HK Stock Market Move | TINGYI (00322) rose by over 4% again to hit a new high in over three months. The stock price has increased by over 10% in the past three days.
Master Kang Holdings (00322) rose by more than 4% again to reach a high of 11.86 Hong Kong dollars, hitting a new high since July this year. The stock price has risen by 10% over the past three trading days.
TINGYI (00322) rose by over 4%, reaching a high of 11.86 Hong Kong dollars, the highest since July this year. The stock price has risen by 10% over the past three trading days. As of the time of this report, it has risen by 4.22%, to 11.85 Hong Kong dollars, with a turnover of 2.83 billion Hong Kong dollars.
On the news front, Goldman Sachs recently released a report stating that on Monday (November 3), they conducted a non-deal roadshow with Tingyi and Kangshifu management at the Food and Beverage Enterprises Day. Kangshifu is currently facing challenges in achieving its sales target for the 2025 fiscal year (originally expected to be flat to low single-digit annual growth), mainly due to the weakness in the beverage business; however, the profit target (annual recurring net profit growth in double digits) is still expected to be achieved, mainly due to pricing base effects, tailwinds in costs, efficiency improvement measures, and strict promotional management. Looking ahead to 2026, Kangshifu management has reiterated that improving profit margins will be a core focus, with the potential to resume revenue growth trajectory and continue to drive efficiency improvement measures. The company typically locks in purchases of various raw materials for periods ranging from two weeks to several months.
Related Articles

SUNAC(01918): Planned to be approved by the High Court, with effective date on November 5th.

AAC TECH (02018) spent 11.4892 million Hong Kong dollars on November 5 to repurchase 300,000 shares.

C-MER MEDICAL (03309) spent 366,400 Hong Kong dollars on November 5 to repurchase 204,000 shares.
SUNAC(01918): Planned to be approved by the High Court, with effective date on November 5th.

AAC TECH (02018) spent 11.4892 million Hong Kong dollars on November 5 to repurchase 300,000 shares.

C-MER MEDICAL (03309) spent 366,400 Hong Kong dollars on November 5 to repurchase 204,000 shares.

RECOMMEND

Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025

Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025

Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025


